Amphastar Pharmaceuticals, Inc. (AMPH) Net income 2016–2025
Amphastar Pharmaceuticals, Inc. (AMPH) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$98.1MFY2025 · since FY2016: $9.8M → $98.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $98.1M | -38.5% |
| FY2024 | $159.5M | +16.0% |
| FY2023 | $137.5M | +50.5% |
| FY2022 | $91.4M | +47.1% |
| FY2021 | $62.1M | +4327.4% |
| FY2020 | $1.4M | -97.1% |
| FY2019 | $48.9M | +952.9% |
| FY2018 | -$5.7M | -257.3% |
| FY2017 | $3.6M | -62.9% |
| FY2016 | $9.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AMPH financial trends
AMPH RevenueAMPH Net marginAMPH Gross profitAMPH Gross marginAMPH Operating incomeAMPH Operating marginAMPH Operating cash flowAMPH Free cash flowAMPH Capital expendituresAMPH Return on equityAMPH Stock buybacksAMPH Dividends paidAMPH Total assetsAMPH Total liabilitiesAMPH Shareholders’ equityAMPH overview →